™Your Policy Risk Impact Agent
80 chapters · 1,674 sections in this title.
S.C. Code Ann. § 44-137-10 Definitions
4.3K chars
As used in this chapter: (1) "Eligible patient" means an individual who: (a) has a terminal illness, attested to by a treating physician; (b) has, in consultation with a treating physician, considered and exhausted all other treatment options currently approved by the United Stat…
S.C. Code Ann. § 44-137-20 Availability to eligible patients of investigational drug, biological product, or device; compensation; costs
0.8K chars
(A) A manufacturer of an investigational drug, biological product, or device may make available to an eligible patient, and an eligible patient may request, the manufacturer's investigational drug, biological product, or device. Nothing in this article shall be construed to requi…
S.C. Code Ann. § 44-137-30 No liability to heirs for outstanding debt related to treatment with investigational drug, biological product, or device
0.3K chars
If an eligible patient dies while being treated with an investigational drug, biological product, or device, the eligible patient's heirs are not liable for any outstanding debt related to the treatment, including any costs attributed to lack of insurance coverage for the treatme…
Sanctions against health care providers prohibited
0.6K chars
(A) A licensing board shall not revoke, fail to renew, suspend, or take any other disciplinary action against a health care provider licensed in this State, based solely on the health care provider's recommendations to an eligible patient regarding access to or treatment with an …
